M. Sabbagh

ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium

Jagan A. Pillai, D. Tsuang, J. Fleisher, 2023, Alzheimer's & Dementia.

Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer’s Disease

M. Sabbagh, A. Burstein, I. Dunn, 2018, The Journal of Prevention of Alzheimer's Disease.

Type 2 Diabetes Comorbidity and Cognitive Decline in Patients with Alzheimer's Disease.

B. Decourt, G. Allenback, M. Sabbagh, 2023, Journal of Alzheimer's disease : JAD.